interesting, a 2nd self professed expert ID. My experience with posters that call themselves experts is that they are anything but experts in TA, Regulatory, or Trading...RG. You are likely a flunkee who gets paid by the post from a hedge fund to spread FUD. "Expert" should consider a more noble profession that adds value to society.
I will agree that company communication of cost cutting and a strategy is lacking and overdue.
he had at least 7 more years to exercise, or not, so what's your next theory, with all due respect. He's a smart and talented guy, so why is he selling???
I totally agree, selling most of his stock is quite concerning. CFO also sold most of his free, low-priced options. Watch these self serving option pigs reload their boat with more options soon. Should have sold this POS and taken the tax hit long ago, most of my other stocks know how to go up!
must have missed something, CA is the only ARNA exec in which I am confident. There are certainly other talented people there in R&D, but CFO, CEO, all other communicators except CA, not so good IMO.
looks like the small pullback was indeed a good opportunity. I looked at the chart last night, chart looked like more st correction was coming, but market is strong and stock is moving higher once again.
I would love to see REGN buy IMGN and add ADC platform, products, molecules and discovery expertise to their oncology pipeline. IMGN has great technology and discovery talent, but needs stronger executive leadership and development expertise and REGN seems very strong.
so far, so good, ascending the mountain toward $18 once again. May have to stop for oxygen before attempting the summit again. We don't want to see another failure at the top. This is one strong market, IMGN has been a laggard, but starting to play catch up. Not sure how one remains short in a good biotech equity unless the short position is paired with SGEN, or ECYT.
Better seek to partner with, or acquire better technology and stronger partners like IMGN, SGEN, or ECYT because it's obvoius PFE does not know ADC.
Reg"expert" seems desperate today, are you the same poster as the tradingexpert on the ACAD MB, who has been talking about shorting the stock since $5 (now $14)?
could be off-market, or on an exchange that your broker does not use. I have found Scottrade's OptionsFirst to be an excellent trading platform. I get very good fills, good prices, I often get price improvement and very low costs, I get a volume discount, but I won't be using it on any more ARNA calls since they always expire worthless.
Keep up the good work on the social media angle, we need all hands on deck to beat these criminal shorts. You can bet shorts will try to counder with an anti-Belviq page. They will stop at nothing to win at the expense of longs.
I would take 1/10th of a share of REGN, that company is well managed and hugely successful. Unfortunately, REGN has so many in-house opportunities that they don't need to acquire. Very interesting company, I wish I had done more DD on them when they were $50 not that long ago. Even at this high price, the PE is not unreasonable. Looks like it wants to correct, so maybe it will be available at a lower price soon.
Good catch on the insider activity, I missed this. On the one hand, there was some insider selling in ACAD in the $8+ range not long ago and it's $14+ today. On the other hand, I always worry when a CFO sells stock. Maybe TSRX will sell some stock in the not too distant future unless they find a deep pocketed partner. As far as the distributes shares, I would expect most of them to be sold, hence the lack of sustainable upward movement for now. TSRX might be stuck in a trading range until the shares are sold. All IMO, not advice, I am long.
on the + side, I am making good money trading IMGN, on the - side, I have a bunch of long, non-trading shares that are not doing much and trading takes time and effort. If I had only allocated more in ACAD I would be playing a lot more golf, it's up 7x+ in under a year, what a stock! Not that I am complaining for any of these Blessings, well maybe AVEO #$%$!
the stock was trading at $2.00 or less not all that long before the acquisition if I recall correctly. HGSI management had plenty of time to succeed, they started out well, did some very interesting research, then let spending get out of control. Anyway, we are on the same side, hoping for an ARNA win before we grow old and die and not big fans of Spencer the wannabe biotech "analyst".